CFN Media Interviews with Eden Labs
Rachelle Gordon
December 21st, 2017
News
Plant extraction has been around for thousands of years, being used to create essential oils, food flavorings, and nutraceuticals – just to name a few. Eden Labs is one of the world-leaders in the development of modern distillation and extraction equipment, and offers both technical and consulting services to their many clients. The company’s deep-rooted experience has led the company to set the gold standard in the space.
CFN Media recently sat down with AC Braddock, CEO of Eden Labs, regarding the exploding cannabis extraction market and how the company is poised to dominate domestically and across the globe.
Rachelle Gordon: What is Eden Labs?
AC Braddock: Eden engineers extraction and distillation equipment for multiple botanical industries, including cannabis. We also provide process development to help companies unleash the components in plants to create the products that companies are building their business models on. Eden Labs takes the products our clients want and we work backwards to figure out what kind of processing assistance that they may need. Eden is also a Team of highly intelligent people who have a wide variety of skill sets and back grounds. We work in a culture of collaboration and individual accountability. This reveals itself in our products and our customer service. All of this has built a brand we are very proud of and continue to expand by positively influencing industries and communities.
RG: What sets Eden Labs apart from potential competitors?
AB: Longevity, vision and connectivity. We pioneered the extraction space in Cannabis for instance. We still have the most efficient technology, and we’re continually improving it. In the modern world, I think it is crucial that businesses are connected with consumers and trends in a way that is directly associated with mission statement, and modern business practice, like being a socially responsible corporate entity. That has really made our brand unbelievably strong and respected and has also created a tremendous amount of trust.
Another thing that makes us unique is our extensive knowledge in of all kinds botanical extractions. We have made systems for flavoring companies, Bio-fuels, herbal liquors and the nutraceutical market, which is a $200-plus billion industry worldwide, and it is also one of the fastest growing markets. It’s very similar to cannabis, where you’re taking plants and using them nutritionally and medicinally to promote health and wellness, and to substitute synthetic products that people are tired of putting in and on their bodies.
That is our mission as a company – to be able to push that technology through multiple different industries and scale them. Having been in the space so long, we have focused our growth around the growth of the industries we support and especially the expansion of our clients, by providing industrial systems. For example, 6000-liter industrial systems for hops or hemp. You’re going to need to a system that size in order to do hemp, because there’s not a lot of oil in the plant material, so you have to scale the extraction process considerably. The superior efficiencies of scale for supercritical co2 has been proven in the hops industry, but small-scale systems are essential for R&D, start-ups, and launching new products. Therefore, Eden Labs creates systems anywhere from 1 liter to 6,000 liters. There’s many different supply chain opportunities and also scalability. Some of those larger systems run anywhere from $10 million to $18 million.
RG: What are your projections for growth?
AB: Our current focus is definitely, on international growth, and providing scalable solutions so that our successful customers are able to expand and grow their businesses. As hemp continues to be legalized, there is going to be an even larger demand for extraction services. The next few years have a hockey stick growth projection for cannabis, both recreationally and medically. They’re both very different markets, and both have an impressive and exciting potential for growth. The majority of the market is changing and it will eventually be focused on people over the age of 50 and women; we’ve barely scratched the surface on this market with those demographics.
RG: What should potential business partners/investors know about Eden Labs?
AB: In our 22 year existence, we have been completely self-funded. However, we are now looking for investments. We’re currently between a $10 million and $20 million company, which is a plateau level for most companies. We have a couple of projects on deck and could easily do $50 million in a year if we had the right partners.
We’ve been approached with investment offers before and I’m often asked, “what would that look like? Would that be an acquisition, would that be a majority interest? The answer completely depends on what the other company brings to the table. Because of our experience and capabilities, we want “smart money”. An Entity or person that could fill in places where we are limited or lacking to create a true powerhouse of innovation, experience and manufacturing. There’s a certain type of synergy that is imperative in a partnership that we haven’t quite found yet. However, we’re still hoping and investigating, because we do have a couple of new products that we want to launch that are possibly quite disruptive.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Rachelle Gordon
Rachelle Gordon is a Minneapolis-based writer. Find her online at www.rachellegordon.net.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
ICC International Cannabis’ corporate mandate is to plan, design, build and operate the highest quality, lowest cost Cannabis production, processing and distribution facilities worldwide.
Chemesis International is a vertically integrated global leader in the cannabis industry, currently operating within Puerto Rico, and California.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
